DecisionPoint Financial
BSX icon

DecisionPoint Financial’s Boston Scientific BSX Stock Holding History

DecisionPoint Financial’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$303 Buy
7
+2
+40% +$93 ﹤0.01% 916
2026
Q2 		$216 Sell
5
-61
-92% -$3.31K ﹤0.01% 923
2026
Q1 		$4.14K Hold
66
– – ﹤0.01% 235
2025
Q4 		$6.29K Hold
66
– – ﹤0.01% 227
2025
Q3 		$6.33K Hold
66
– – ﹤0.01% 160
2025
Q2 		$6.92K Buy
+66
New +$6.68K ﹤0.01% 162

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
ZWJ Investment Counsel
ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

DecisionPoint Financial's BSX Position: Q3 2026 in Review

DecisionPoint Financial increased its Boston Scientific (BSX) stake by 40% in Q3 2026, buying an estimated $93 and bringing the position to 7 shares worth $303. The position accounts for ﹤0.01% of the portfolio, ranked #916.

DecisionPoint Financial first reported a position in BSX in Q2 2025 and has held it in 6 quarters since. The position peaked at $6.92K in Q2 2025. 478 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • DecisionPoint Financial held 7 shares of Boston Scientific worth $303 as of Q3 2026.
  • DecisionPoint Financial bought 2 Boston Scientific shares in Q3 2026, an estimated $93.
  • Boston Scientific made up ﹤0.01% of DecisionPoint Financial's portfolio in Q3 2026, its #916 holding.
  • DecisionPoint Financial first reported a position in Boston Scientific in Q2 2025 and has held it in 6 quarters since.
  • DecisionPoint Financial's Boston Scientific position peaked at $6.92K in Q2 2025.
  • 478 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on DecisionPoint Financial's 13F filing for Q3 2026, filed 27 Oct 2026.